Skip to main content
logo
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.2860
0.00 (0.00%)
Last updated: Aug 24, 2026, 8:04 AM CET

Biomark Diagnostics Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
303614171011
Market Cap Growth
50.93%148.17%-15.29%61.96%-7.18%-45.46%
Enterprise Value
313515181212
Last Close Price
0.290.340.140.190.130.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
819.81961.85145.04152.12100.50356.91
PB Ratio
148.05173.7012.85-40.73-13.42-24.67
P/TBV Ratio
148.05173.7012.85---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
-952.24154.52161.35110.73393.16

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
4.294.290.64-2.54-1.44-3.09
Net Debt / Equity Ratio
1.241.24-0.78-2.28-1.37-2.49
Net Debt / EBITDA Ratio
-0.24-0.240.67-0.82-0.86-1.24
Net Debt / FCF Ratio
-0.37-0.371.24-1.41-1.72-1.25
Asset Turnover
0.020.020.070.180.140.04
Quick Ratio
0.970.972.140.160.060.31
Current Ratio
0.990.992.140.160.080.33
Return on Equity (ROE)
-142.59%-142.59%-340.70%---
Return on Assets (ROA)
-43.06%-43.06%-60.59%-117.29%-104.38%-66.20%
Return on Capital Employed (ROCE)
-225.70%-225.70%-107.60%1099.30%197.40%4328.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-3.01%-2.57%-8.62%-5.75%-11.94%-9.27%
FCF Yield
-2.23%-1.90%-4.90%-3.98%-5.96%-8.06%
Buyback Yield / Dilution
-15.58%-15.58%-6.67%-2.97%-6.22%-6.31%